| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4dae7331034b6b26116b7c2f7acb115 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-62 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-62 |
| filingDate |
1980-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1982-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01ea4759788420eaa94b108f967db6aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_859c24886c1acf37105a33ebed78f3b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fd79613302d42f7e9ed0c2430f5e96 |
| publicationDate |
1982-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4317935-A |
| titleOfInvention |
Bicyclo aldehyde and process for preparation |
| abstract |
Stable biologically active thromboxane A2 analogues having the formula: <IMAGE> wherein R1 is OR3, where R3 represents hydrogen or a pharmaceutically acceptable cation or lower alkyl group; or R1 is NR4R5 where R4 and R5 are the same or different substituents selected from the group consisting of hydrogen and lower alkyl group; and R2 is hydrogen or an -OH group. The thromboxane analogues are potent thrombotic agents, useful in cardiovascular treatment. |
| priorityDate |
1979-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |